There is one clear difference you have probably overlooked. The companies you quote are all billion dollar companies with piles of cash to play with, and can afford the occasional setback.
A startup can't afford to be taking over companies with money it does not have, otherwise CRs and CNs at disastrous terms are inevitable.... as as happened with XPED after the purchase of JCT. You don't have to be a financial wizard, just financially prudent.
- Forums
- ASX - By Stock
- OAK
- Ann: Lenze IPark 20 Million Order
Ann: Lenze IPark 20 Million Order, page-146
Featured News
Add OAK (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.4¢ |
Change
0.004(6.67%) |
Mkt cap ! $1.727M |
Open | High | Low | Value | Volume |
6.4¢ | 6.4¢ | 6.4¢ | $513 | 8.021K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14135 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.5¢ | 28474 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14135 | 0.060 |
1 | 100000 | 0.059 |
1 | 82000 | 0.055 |
1 | 55000 | 0.053 |
1 | 100000 | 0.046 |
Price($) | Vol. | No. |
---|---|---|
0.065 | 28474 | 1 |
0.095 | 20000 | 1 |
0.105 | 1524 | 1 |
0.175 | 22450 | 1 |
0.180 | 30000 | 1 |
Last trade - 12.20pm 15/11/2024 (20 minute delay) ? |
Featured News
OAK (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online